X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with VENUS REMEDIES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs VENUS REMEDIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. VENUS REMEDIES FDC LTD./
VENUS REMEDIES
 
P/E (TTM) x 24.7 -535.8 - View Chart
P/BV x 5.2 0.2 3,393.9% View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 FDC LTD.   VENUS REMEDIES
EQUITY SHARE DATA
    FDC LTD.
Mar-14
VENUS REMEDIES
Mar-17
FDC LTD./
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs144143 100.5%   
Low Rs7965 121.5%   
Sales per share (Unadj.) Rs47.6324.2 14.7%  
Earnings per share (Unadj.) Rs7.66.4 118.7%  
Cash flow per share (Unadj.) Rs9.040.6 22.2%  
Dividends per share (Unadj.) Rs2.250-  
Dividend yield (eoy) %2.00-  
Book value per share (Unadj.) Rs47.5366.0 13.0%  
Shares outstanding (eoy) m177.8312.34 1,441.1%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.30.3 729.8%   
Avg P/E ratio x14.616.2 90.2%  
P/CF ratio (eoy) x12.32.6 482.2%  
Price / Book Value ratio x2.30.3 824.4%  
Dividend payout %29.60-   
Avg Mkt Cap Rs m19,7841,282 1,543.0%   
No. of employees `000NA0.9 0.0%   
Total wages/salary Rs m1,221251 486.3%   
Avg. sales/employee Rs ThNM4,430.1-  
Avg. wages/employee Rs ThNM278.0-  
Avg. net profit/employee Rs ThNM87.6-  
INCOME DATA
Net Sales Rs m8,4594,000 211.4%  
Other income Rs m39423 1,733.7%   
Total revenues Rs m8,8524,023 220.0%   
Gross profit Rs m2,070785 263.8%  
Depreciation Rs m249422 59.1%   
Interest Rs m31344 9.0%   
Profit before tax Rs m2,18442 5,186.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m606-37 -1,636.6%   
Profit after tax Rs m1,35379 1,710.7%  
Gross profit margin %24.519.6 124.8%  
Effective tax rate %27.7-87.9 -31.6%   
Net profit margin %16.02.0 809.1%  
BALANCE SHEET DATA
Current assets Rs m4,3552,606 167.1%   
Current liabilities Rs m1,7921,980 90.5%   
Net working cap to sales %30.315.6 193.7%  
Current ratio x2.41.3 184.7%  
Inventory Days Days44128 34.6%  
Debtors Days Days2543 57.2%  
Net fixed assets Rs m3,0255,353 56.5%   
Share capital Rs m179123 144.7%   
"Free" reserves Rs m8,2434,393 187.6%   
Net worth Rs m8,4534,516 187.2%   
Long term debt Rs m111,618 0.7%   
Total assets Rs m10,5578,291 127.3%  
Interest coverage x71.41.1 6,362.3%   
Debt to equity ratio x00.4 0.4%  
Sales to assets ratio x0.80.5 166.1%   
Return on assets %13.15.1 257.1%  
Return on equity %16.01.8 913.9%  
Return on capital %23.56.3 373.8%  
Exports to sales %13.30-   
Imports to sales %3.318.4 18.2%   
Exports (fob) Rs m1,126NA-   
Imports (cif) Rs m283736 38.4%   
Fx inflow Rs m1,1460-   
Fx outflow Rs m355736 48.3%   
Net fx Rs m791-736 -107.4%   
CASH FLOW
From Operations Rs m1,485997 148.9%  
From Investments Rs m-620-461 134.3%  
From Financial Activity Rs m-753-571 131.8%  
Net Cashflow Rs m113-35 -321.4%  

Share Holding

Indian Promoters % 68.9 32.9 209.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 0.2 2,611.1%  
FIIs % 7.5 0.6 1,293.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 66.4 28.6%  
Shareholders   23,730 20,121 117.9%  
Pledged promoter(s) holding % 0.0 36.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   NOVARTIS  TORRENT PHARMA  FRESENIUS KABI ONCO.  STERLING BIOTECH  ASTRAZENECA PHARMA  

Compare FDC LTD. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Tata Steel & Dr. Reddy's Top Losers(09:30 am)

Asian share markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 1.3% while the Hang Seng is down 1%. The Shanghai Composite is trading down by 0.8%.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Looking Beyond the Colourful Prism of This Airline Company(Sector Info)

May 10, 2018

Can Interglobe Aviation Safely Fly Out of Turbulence?

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


May 23, 2018 12:35 PM

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. - ALEMBIC PHARMA COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS